Based on the above considerations, this study aims to investigate whether overexpression of Nanog increases the malignancy of colon26 cells and whether EVs derived from Nanog-overexpressing colon cancer cells can suppress cancer metastasis, and to analyze the involvement of immune cells, especially macrophages, in the mechanism. The gene discussed is NANOG; the disease is cancer.